BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 32789787)

  • 1. Ion Channel Dysregulation in Head and Neck Cancers: Perspectives for Clinical Application.
    Del-Río-Ibisate N; Granda-Díaz R; Rodrigo JP; Menéndez ST; García-Pedrero JM
    Rev Physiol Biochem Pharmacol; 2021; 181():375-427. PubMed ID: 32789787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and clinical significance of the Kv3.4 potassium channel subunit in the development and progression of head and neck squamous cell carcinomas.
    Menéndez ST; Rodrigo JP; Allonca E; García-Carracedo D; Alvarez-Alija G; Casado-Zapico S; Fresno MF; Rodríguez C; Suárez C; García-Pedrero JM
    J Pathol; 2010 Aug; 221(4):402-10. PubMed ID: 20593490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HERG1A potassium channel is the predominant isoform in head and neck squamous cell carcinomas: evidence for regulation by epigenetic mechanisms.
    Menéndez ST; Villaronga MÁ; Rodrigo JP; Álvarez-Teijeiro S; Urdinguio RG; Fraga MF; Suárez C; García-Pedrero JM
    Sci Rep; 2016 Jan; 6():19666. PubMed ID: 26785772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TP53-Associated Ion Channel Genes Serve as Prognostic Predictor and Therapeutic Targets in Head and Neck Squamous Cell Carcinoma.
    Sun J; Yu X; Xue L; Li S; Li J; Tong D; Du Y
    Technol Cancer Res Treat; 2020; 19():1533033820972344. PubMed ID: 33243093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein glycosylation in head and neck cancers: From diagnosis to treatment.
    Rasheduzzaman M; Kulasinghe A; Dolcetti R; Kenny L; Johnson NW; Kolarich D; Punyadeera C
    Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188422. PubMed ID: 32853734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA expression profile in head and neck cancer: HOX-cluster embedded microRNA-196a and microRNA-10b dysregulation implicated in cell proliferation.
    Severino P; Brüggemann H; Andreghetto FM; Camps C; Klingbeil Mde F; de Pereira WO; Soares RM; Moyses R; Wünsch-Filho V; Mathor MB; Nunes FD; Ragoussis J; Tajara EH
    BMC Cancer; 2013 Nov; 13():533. PubMed ID: 24209638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of miRNA in head and neck squamous cell carcinoma.
    Masood Y; Kqueen CY; Rajadurai P
    Expert Rev Anticancer Ther; 2015 Feb; 15(2):183-97. PubMed ID: 25367254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UBE2C promotes the progression of head and neck squamous cell carcinoma.
    Jin Z; Zhao X; Cui L; Xu X; Zhao Y; Younai F; Messadi D; Hu S
    Biochem Biophys Res Commun; 2020 Mar; 523(2):389-397. PubMed ID: 31870550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Six Glycolysis-Related Genes as Prognostic Risk Markers Can Predict the Prognosis of Patients with Head and Neck Squamous Cell Carcinoma.
    Chen L; He X; Yi S; Liu G; Liu Y; Ling Y
    Biomed Res Int; 2021; 2021():8824195. PubMed ID: 33628816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and analysis of genes associated with head and neck squamous cell carcinoma by integrated bioinformatics methods.
    Jin Y; Yang Y
    Mol Genet Genomic Med; 2019 Aug; 7(8):e857. PubMed ID: 31304688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent aberrant expression of the human ether à go-go (hEAG1) potassium channel in head and neck cancer: pathobiological mechanisms and clinical implications.
    Menéndez ST; Villaronga MA; Rodrigo JP; Alvarez-Teijeiro S; García-Carracedo D; Urdinguio RG; Fraga MF; Pardo LA; Viloria CG; Suárez C; García-Pedrero JM
    J Mol Med (Berl); 2012 Oct; 90(10):1173-84. PubMed ID: 22466864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer.
    Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y
    Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791
    [No Abstract]   [Full Text] [Related]  

  • 13. DOCK8 Serves as a Prognostic Biomarker and Is Related to Immune Infiltration in Patients With HPV Positive Head and Neck Squamous Cell Carcinoma.
    Zhang Z; Bao Y; Zhou L; Ye Y; Fu W; Sun C
    Cancer Control; 2021; 28():10732748211011951. PubMed ID: 33910393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of TRPC6 as a possible candidate target gene within an amplicon at 11q21-q22.2 for migratory capacity in head and neck squamous cell carcinomas.
    Bernaldo de Quirós S; Merlo A; Secades P; Zambrano I; de Santa María IS; Ugidos N; Jantus-Lewintre E; Sirera R; Suarez C; Chiara MD
    BMC Cancer; 2013 Mar; 13():116. PubMed ID: 23497198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of ZEB2-AS1 promotes epithelial-to-mesenchymal transition and metastasis by stabilizing ZEB2 mRNA in head neck squamous cell carcinoma.
    Diao P; Ge H; Song Y; Wu Y; Li J; Li Z; Yang J; Wang Y; Cheng J
    J Cell Mol Med; 2019 Jun; 23(6):4269-4280. PubMed ID: 30950191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic Drivers of Head and Neck Squamous Cell Carcinoma: Aberrant Splicing Events, Mutational Burden, HPV Infection and Future Targets.
    Dlamini Z; Alaouna M; Mbatha S; Bhayat A; Mabongo M; Chatziioannou A; Hull R
    Genes (Basel); 2021 Mar; 12(3):. PubMed ID: 33804181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating tumour cells in metastatic head and neck cancers.
    Kulasinghe A; Perry C; Jovanovic L; Nelson C; Punyadeera C
    Int J Cancer; 2015 Jun; 136(11):2515-23. PubMed ID: 25111594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circadian (De)regulation in Head and Neck Squamous Cell Carcinoma.
    Rahman S; Kraljević Pavelić S; Markova-Car E
    Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31151182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of SERPINE1, PLAU and ACTA1 as biomarkers of head and neck squamous cell carcinoma based on integrated bioinformatics analysis.
    Yang K; Zhang S; Zhang D; Tao Q; Zhang T; Liu G; Liu X; Zhao T
    Int J Clin Oncol; 2019 Sep; 24(9):1030-1041. PubMed ID: 30937621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinicopathological significances and biological functions of parafibromin expression in head and neck squamous cell carcinomas.
    Zhang Z; Yang XF; Huang KQ; Ren L; Gou WF; Shen DF; Zhao S; Sun HZ; Takano Y; Zheng HC
    Tumour Biol; 2015 Dec; 36(12):9487-97. PubMed ID: 26124004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.